Walgreens Boots Alliance Inc. (WBA)
NASDAQ (NGS) NASDAQ (NGS) Primary 
WBA soars: Walgreens stock up 25% on earnings despite store closures, as investors hope the worst is over
Shares in Walgreens Boots Alliance, Inc. (Nasdaq: WBA) are surging this morning after the company reported its first quarter fiscal 2025 results. As of the time of this writing, WBA shares are currently up over 25% to $11.53 per share.
S&P 500 Gains and Losses Today: Walgreens Stock Pops After Promising Results
Major U.S. equities indexes plunged as the markets returned to action Friday following a day of mourning for former President Jimmy Carter.
Walgreens Pharmacy Strength And CEO Comments Toss Cold Water On Sycamore Deal
The improving retail pharmacy business of Walgreens Boots Alliance and comments from the company's chief executive are convincing Wall Street the drugstore chain is unlikely headed for a buyout from private equity anytime soon.
Walgreens: Share Price Spike On Recovery Plan Success May Be Sustainable
Walgreens Boots Alliance stock has plummeted over 65% since 2020, but surged by >25% today following strong Q1 2025 earnings and revenue outperformance. The company faces significant challenges, including high debt, store closures, and profitability issues, but management's strategic turnaround plan shows promise. Walgreens aims to improve reimbursement terms, streamline operations, and boost cash flow, with a focus on its U.S. retail pharmacy business.
Walgreens CEO: ‘Turnaround Will Take Time'
For Walgreens Boots Alliance CEO Tim Wentworth, the company's turnaround process is not a sprint but a marathon. “We still have substantial work to do here,” he told analysts during the company's first-quarter earnings call Friday (Jan. 10).
Stock Of The Day: Is Walgreens Breaking Out?
Walgreens Boots Alliance, Inc. WBA shares are trading significantly higher Friday. The company posted earnings that were higher than estimates.
Walgreens Is Soaring on Friday. Here's Why The Beaten-Down Healthcare Stock Bounced.
Walgreens Boots Alliance (WBA 26.52%), better known as Walgreens, was one of the worst-performing stocks of 2024. Although the S&P 500 index rose by more than 20% for the year, Walgreens dropped by a staggering 64% due to consumer spending headwinds and poor performance from its primary care business efforts.
Walgreens Boots Alliance, Inc. (WBA) Q1 2025 Earnings Call Transcript
Walgreens Boots Alliance, Inc. (NASDAQ:WBA ) Q1 2025 Earnings Conference Call January 10, 2024 8:30 AM ET Company Participants Eric Wasserstrom - SVP, IR Tim Wentworth - CEO Manmohan Mahajan - Global CFO Conference Call Participants Lisa Gill - JPMorgan Eric Percher - Nephron Research Charles Rhyee - TD Securities Michael Cherny - Leerink Partners Kevin Caliendo - UBS Elizabeth Anderson - Evercore ISI Ann Hynes - Mizuho Group George Hill - Deutsche Bank Brian Tanquilut - Jefferies Operator Good day, and thank you for standing by. Welcome to Walgreens Boots Alliance First Quarter Results Conference Call.
Embattled Walgreens Stock Soars After Earnings
Walgreens Boots Alliance Inc (NASDAQ:WBA) had a rough 2024.
Walgreens Boots Alliance shares jump after Q1 earnings beat, upbeat outlook
Walgreens Boots Alliance Inc (NASDAQ:WBA, ETR:W8A) saw its shares surge 24% in Friday morning trading after reporting stronger-than-expected first-quarter earnings and maintaining an optimistic full-year forecast. For Q1 FY25, Walgreens posted adjusted earnings per share (EPS) of $0.51, beating analysts' revised expectations of $0.37.
Walgreens (WBA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Walgreens (WBA) give a sense of how its business performed in the quarter ended November 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Walgreens Boots Alliance (WBA) Q1 Earnings and Revenues Surpass Estimates
Walgreens Boots Alliance (WBA) came out with quarterly earnings of $0.51 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.66 per share a year ago.
